141 related articles for article (PubMed ID: 12091216)
1. Metyrapone for Cushing's syndrome.
Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
[No Abstract] [Full Text] [Related]
2. Metyrapone for delirium due to Cushing's syndrome induced by occult ectopic adrenocorticotropic hormone secretion.
Kawashima T; Oda M; Kuno T; Ueki H; Yamada S; Hisatomi A
J Clin Psychiatry; 2004 Jul; 65(7):1019-20. PubMed ID: 15291697
[No Abstract] [Full Text] [Related]
3. Successful control of Cushing's disease in the elderly with long term metyrapone.
Donckier J; Burrin JM; Ramsay ID; Joplin GF
Postgrad Med J; 1986 Aug; 62(730):727-30. PubMed ID: 3022270
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
[No Abstract] [Full Text] [Related]
5. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
[TBL] [Abstract][Full Text] [Related]
6. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
Hunter PR; Ross W; Hall R; Cook DB
Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
[No Abstract] [Full Text] [Related]
8. Primary therapy for Cushing's disease with metyrapone.
Dickstein G; Lahav M; Shen-Orr Z; Edoute Y; Barzilai D
JAMA; 1986 Mar; 255(9):1167-9. PubMed ID: 3003415
[TBL] [Abstract][Full Text] [Related]
9. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
Vong CH; Forest M; Nicolino M
J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777
[No Abstract] [Full Text] [Related]
11. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature review.
Achong N; D'Emden M; Fagermo N; Mortimer R
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):96-100. PubMed ID: 22188308
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic possibilities in Cushing's syndrome.
Melby JC
N Engl J Med; 1971 Jul; 285(5):288-9. PubMed ID: 4326258
[No Abstract] [Full Text] [Related]
14. [Cushing's syndrome].
Shimizu N; Kato T
Naika; 1971 Jun; 27(6):1202-6. PubMed ID: 4326410
[No Abstract] [Full Text] [Related]
15. Cushing's Syndrome.
Pivonello R; De Martino MC; De Leo M; Lombardi G; Colao A
Endocrinol Metab Clin North Am; 2008 Mar; 37(1):135-49, ix. PubMed ID: 18226734
[TBL] [Abstract][Full Text] [Related]
16. Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
Beardwell CG; Adamson AR; Shalet SM
Clin Endocrinol (Oxf); 1981 May; 14(5):485-92. PubMed ID: 6273022
[TBL] [Abstract][Full Text] [Related]
17. Metyrapone is useful only as adjunctive therapy in Cushing's disease.
Orth DN
Ann Intern Med; 1978 Jul; 89(1):128-30. PubMed ID: 208445
[No Abstract] [Full Text] [Related]
18. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
19. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
20. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
